Mesh-Wrapped Bioceramic Orbital Implant from FCI Ophthalmics Inc.

  • Mesh-Wrapped Bioceramic Orbital Implant

Description

FCI Ophthalmics has received the FDA approval to market its Mesh-Wrapped Bioceramic Orbital Implant for use in enucleation procedures in the United States. The implant is made of the porous, strong, non-brittle biomaterial alumina (AL2, O3), and features highly uniform interconnected pores of approximately 500µm in size. The vicryl (polyglactin 910) mesh wrapping allows the suturing of the muscles directly onto the implant.
  • Product Specs
  • ItemMesh-Wrapped Bioceramic Orbital Implant
  • CompanyFCI Ophthalmics Inc.
  • PriceGet quote
  • Features
  • The extensive pore system enhances fibrovascular ingrowth which keeps the implant from migrating and allows the secure attachment of extraocular muscles, thereby improving implant motility.
  • The implant can be coupled directly to the prosthesis through FCI's unique hydroxyapatite-coated titanium peg and sleeve system.
  • This allows a wide range of prosthetic movements in complete synchrony with the natural eye.
  • Available in 4 sizes from 16-22mm diameters.
  • The Mesh-Wrapped Bioceramic Orbital Implant is lightweight (½ the weight of the HA) and easy to insert.
  • MaterialAlumina with vicryl (polyglactin 910) mesh wrapping.
  • ApprovalUS FDA
  • Product NumberInquire
  • Size16-22 mm
Add to Compare List